Attention bias modification for depression: A systematic review and meta-analysis.
attention bias modification
cognitive deficits
depression
meta-analysis
systematic review
Journal
Frontiers in psychiatry
ISSN: 1664-0640
Titre abrégé: Front Psychiatry
Pays: Switzerland
ID NLM: 101545006
Informations de publication
Date de publication:
2023
2023
Historique:
received:
18
11
2022
accepted:
03
02
2023
entrez:
27
3
2023
pubmed:
28
3
2023
medline:
28
3
2023
Statut:
epublish
Résumé
Depression is a mental health disorder characterized by affective, somatic, and cognitive symptoms. Attention bias modification (ABM) has been widely used to treat depression. However, the results seem inconsistent. We conducted a systematic review and meta-analysis to investigate the efficacy of ABM for depression and to explore the optimal protocol of ABM. Seven databases were systematically searched from their inceptions to 5 October 2022 to include randomized controlled trials (RCTs) of ABM for depression. Two independent reviewers selected the eligible articles, extracted data, and evaluated the risk of bias using version 2 of the Cochrane risk-of-bias tool (ROB 2.0) for randomized trials. The primary outcome was the evaluation of depressive symptoms using widely accepted and validated scales. The secondary outcomes included rumination and attentional control. Meta-analysis was conducted by using RevMan (version 5.4) and Stata (version 12.0). Subgroup analyses and meta-regressions were performed to identify the source of heterogeneity. The certainty of the evidence was assessed using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE). A total of 19 trials involving 20 datasets (1,262 participants) were included. The overall risk of bias in one study was rated as low risk of bias, three studies were considered as high, and the remaining studies were some concerns. Compared with attention control training (ACT), ABM had a greater effect in the improvement of depression (SMD = -0.48, 95% CI -0.80 to -0.17, Due to high heterogeneity and limited studies, not enough current evidence supported that ABM could be an effective intervention to relieve depressive symptoms. More rigorous RCTs are required to verify the benefits and to explore the optimal protocol of ABM training for depression.
Sections du résumé
Background
UNASSIGNED
Depression is a mental health disorder characterized by affective, somatic, and cognitive symptoms. Attention bias modification (ABM) has been widely used to treat depression. However, the results seem inconsistent. We conducted a systematic review and meta-analysis to investigate the efficacy of ABM for depression and to explore the optimal protocol of ABM.
Methods
UNASSIGNED
Seven databases were systematically searched from their inceptions to 5 October 2022 to include randomized controlled trials (RCTs) of ABM for depression. Two independent reviewers selected the eligible articles, extracted data, and evaluated the risk of bias using version 2 of the Cochrane risk-of-bias tool (ROB 2.0) for randomized trials. The primary outcome was the evaluation of depressive symptoms using widely accepted and validated scales. The secondary outcomes included rumination and attentional control. Meta-analysis was conducted by using RevMan (version 5.4) and Stata (version 12.0). Subgroup analyses and meta-regressions were performed to identify the source of heterogeneity. The certainty of the evidence was assessed using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE).
Results
UNASSIGNED
A total of 19 trials involving 20 datasets (1,262 participants) were included. The overall risk of bias in one study was rated as low risk of bias, three studies were considered as high, and the remaining studies were some concerns. Compared with attention control training (ACT), ABM had a greater effect in the improvement of depression (SMD = -0.48, 95% CI -0.80 to -0.17,
Conclusion
UNASSIGNED
Due to high heterogeneity and limited studies, not enough current evidence supported that ABM could be an effective intervention to relieve depressive symptoms. More rigorous RCTs are required to verify the benefits and to explore the optimal protocol of ABM training for depression.
Identifiants
pubmed: 36970284
doi: 10.3389/fpsyt.2023.1098610
pmc: PMC10036757
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1098610Informations de copyright
Copyright © 2023 Xia, Li, Zhang, Zhong, Liu, Gou, Fan, Zhao, Zhang, Ai, Huang, Li and Jin.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Clin Epidemiol. 2011 Apr;64(4):401-6
pubmed: 21208779
J Behav Ther Exp Psychiatry. 2014 Jun;45(2):252-9
pubmed: 24361543
Sci Rep. 2015 Nov 24;5:17138
pubmed: 26598026
J Behav Ther Exp Psychiatry. 2010 Sep;41(3):265-74
pubmed: 20227062
Br J Psychiatry. 2015 Jan;206(1):7-16
pubmed: 25561486
J Psychiatr Res. 2019 Feb;109:145-155
pubmed: 30551021
Br J Psychiatry. 2012 Jul;201(1):71-2
pubmed: 22539781
Behav Res Ther. 2017 May;92:57-67
pubmed: 28257982
Am J Psychiatry. 2008 Aug;165(8):969-77
pubmed: 18628348
J Clin Psychol. 2014 Dec;70(12):1133-57
pubmed: 24652823
Psychiatry Res. 2021 Jun;300:113896
pubmed: 33799199
Psychophysiology. 2018 Jun;55(6):e13051
pubmed: 29266532
J Am Acad Child Adolesc Psychiatry. 2016 Mar;55(3):208-18.e2
pubmed: 26903254
Soc Psychol Personal Sci. 2012 Sep 1;3(5):556-561
pubmed: 22924093
Biol Psychiatry. 2010 May 15;67(10):919-25
pubmed: 20034617
Nat Rev Dis Primers. 2016 Sep 15;2:16065
pubmed: 27629598
Sci Rep. 2018 Dec 11;8(1):17773
pubmed: 30538271
Sci Rep. 2018 Feb 12;8(1):2861
pubmed: 29434331
Psychol Bull. 2011 Nov;137(6):940-58
pubmed: 21728399
Cogn Affect Behav Neurosci. 2010 Mar;10(1):8-20
pubmed: 20233952
Lancet Psychiatry. 2020 Jun;7(6):506-514
pubmed: 32445689
JMIR Serious Games. 2018 Nov 28;6(4):e10993
pubmed: 30487121
Pediatrics. 2016 Jan;137(1):
pubmed: 26702029
Neurobiol Aging. 2009 Apr;30(4):507-14
pubmed: 19231028
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
J Behav Ther Exp Psychiatry. 2021 Jun;71:101621
pubmed: 33202263
Psychol Bull. 2016 Jan;142(1):18-78
pubmed: 26619211
Nutrients. 2020 Aug 13;12(8):
pubmed: 32823643
Depress Anxiety. 2021 Feb;38(2):134-145
pubmed: 32790036
Sci Rep. 2019 Jul 31;9(1):11110
pubmed: 31366954
Autism Res. 2019 Mar;12(3):527-535
pubmed: 30632321
J Clin Epidemiol. 2011 Apr;64(4):380-2
pubmed: 21185693
Am J Psychiatry. 2006 Sep;163(9):1561-8
pubmed: 16946181
Psychol Med. 2021 Mar 26;:1-9
pubmed: 33766151
Depress Anxiety. 2010 Dec;27(12):1135-42
pubmed: 21049527
Soc Psychiatry Psychiatr Epidemiol. 1993 Oct;28(5):239-42
pubmed: 8284737
Sci Rep. 2017 Jun 14;7(1):3449
pubmed: 28615651
J Behav Ther Exp Psychiatry. 2015 Dec;49(Pt A):101-11
pubmed: 25245928
J Abnorm Psychol. 1993 Feb;102(1):20-8
pubmed: 8436695
BMJ. 2017 Sep 21;358:j4008
pubmed: 28935701
Psychon Bull Rev. 2017 Dec;24(6):1686-1717
pubmed: 28092078
J Affect Disord. 2018 Oct 1;238:472-481
pubmed: 29929157
Sci Rep. 2017 Sep 11;7(1):11228
pubmed: 28894106
Clin Psychol Rev. 2011 Feb;31(1):138-45
pubmed: 20817334
JAMA Psychiatry. 2020 Jul 1;77(7):694-702
pubmed: 32186668
Biol Psychiatry. 2012 Oct 1;72(7):572-9
pubmed: 22579509
Int J Environ Res Public Health. 2019 Mar 06;16(5):
pubmed: 30845752
Personal Disord. 2012 Oct;3(4):355-69
pubmed: 22506626
J Affect Disord. 2017 Dec 1;223:175-183
pubmed: 28759865
Lancet. 2021 Nov 6;398(10312):1700-1712
pubmed: 34634250
J Clin Psychol. 2018 Sep;74(9):1594-1606
pubmed: 29542816
Clin Psychol Rev. 2015 Aug;40:76-90
pubmed: 26080314
J Psychiatr Res. 2021 Jun;138:528-534
pubmed: 33984807
Lancet Psychiatry. 2016 May;3(5):415-24
pubmed: 27083119
J Psychiatry Neurosci. 2019 Aug 09;45(1):23-33
pubmed: 31397551
JMIR Mhealth Uhealth. 2018 May 24;6(5):e10034
pubmed: 29793899
Biol Psychiatry. 2010 Dec 1;68(11):982-90
pubmed: 20887977
BMC Med. 2020 Oct 8;18(1):317
pubmed: 33028317
Clin Psychol Rev. 2016 Dec;50:37-49
pubmed: 27693664
J Abnorm Psychol. 2015 Aug;124(3):463-75
pubmed: 25894440
J Child Adolesc Psychopharmacol. 2018 Nov;28(9):620-630
pubmed: 29969293
Behav Ther. 2012 Dec;43(4):724-40
pubmed: 23046776
J Med Internet Res. 2018 Jul 03;20(7):e10668
pubmed: 29970358
Psychol Med. 2021 May;51(7):1211-1219
pubmed: 32063231